USANA Health Sciences (NYSE:USNA) Director Sells $22,704.36 in Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert Fuller sold 1,057 shares of the company’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $21.48, for a total transaction of $22,704.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

USANA Health Sciences Trading Down 6.1%

Shares of NYSE USNA opened at $19.17 on Friday. The business has a 50-day moving average of $25.87 and a 200-day moving average of $28.67. The firm has a market capitalization of $350.33 million, a price-to-earnings ratio of 21.79, a PEG ratio of 0.94 and a beta of 0.61. USANA Health Sciences, Inc. has a 12 month low of $18.69 and a 12 month high of $41.83.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Thursday, October 9th. The company reported $0.56 EPS for the quarter. USANA Health Sciences had a net margin of 1.86% and a return on equity of 6.96%. The firm had revenue of $200.22 million for the quarter. USANA Health Sciences has set its Q3 2025 guidance at -0.150–0.150 EPS. On average, analysts predict that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on USNA shares. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of USANA Health Sciences in a research note on Wednesday, October 8th. Zacks Research lowered USANA Health Sciences from a “hold” rating to a “strong sell” rating in a research note on Tuesday, October 21st. Finally, Wall Street Zen lowered USANA Health Sciences from a “buy” rating to a “hold” rating in a research report on Saturday, October 11th. Two equities research analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average target price of $36.00.

Institutional Investors Weigh In On USANA Health Sciences

A number of large investors have recently modified their holdings of the stock. PNC Financial Services Group Inc. boosted its holdings in shares of USANA Health Sciences by 339.6% during the 1st quarter. PNC Financial Services Group Inc. now owns 998 shares of the company’s stock valued at $27,000 after buying an additional 771 shares in the last quarter. Tower Research Capital LLC TRC increased its stake in shares of USANA Health Sciences by 382.5% during the second quarter. Tower Research Capital LLC TRC now owns 2,398 shares of the company’s stock valued at $73,000 after purchasing an additional 1,901 shares in the last quarter. CWM LLC boosted its position in shares of USANA Health Sciences by 109.7% in the 2nd quarter. CWM LLC now owns 2,762 shares of the company’s stock worth $84,000 after purchasing an additional 1,445 shares in the last quarter. AlphaQuest LLC raised its stake in USANA Health Sciences by 300.9% during the first quarter. AlphaQuest LLC now owns 3,412 shares of the company’s stock valued at $92,000 after buying an additional 2,561 shares during the last quarter. Finally, Quantbot Technologies LP grew its stake in shares of USANA Health Sciences by 19.5% in the second quarter. Quantbot Technologies LP now owns 3,957 shares of the company’s stock worth $121,000 after acquiring an additional 646 shares during the last quarter. Institutional investors own 54.25% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.